Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis

Journal of Hepatology

Volumn 46, Issue 6, 2007, Pages 1099-1103

  van Os, Erik ^a   van den Broek, Walter W ^a   Mulder, Paul G H ^a   ter Borg, Pieter C J ^a   Bruijn, Jan A ^a   van Buuren, Henk R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Beck depression inventory (BDI); Cytokines; Depressive disorder; Fatigue; Interleukin; Sickness syndrome

Indexed keywords

URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SCORING SYSTEM; SELF REPORT; STRUCTURED INTERVIEW;

ADULT; AGED; CHOLESTASIS, INTRAHEPATIC; COMORBIDITY; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 34247571362     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.01.036     Document Type: Article

References (25)

1. Weissman M.M., Bland R.C., Canino G.J., Faravelli C., Greenwald S., Hwu H.G., et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 276 (1996) 293-299
2. Bijl R.V., van Zessen G., and Ravelli A. Psychiatric morbidity among adults in The Netherlands: the NEMESIS-Study. II. Prevalence of psychiatric disorders. Netherlands Mental Health Survey and Incidence Study. Ned Tijdschr Geneeskd 141 (1997) 2453-2460
3. Katon W., and Sullivan M.D. Depression and chronic medical illness. J Clin Psychiatry 51 (1990) 3-11 discussion 12-14
4. Evans D.L., Charney D.S., Lewis L., Golden R.N., Gorman J.M., Krishnan K.R., et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 58 (2005) 175-189
5. Wells K.B., Golding J.M., and Burnam M.A. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 145 (1988) 976-981
6. van Hoogstraten H.J., Hansen B.E., van Buuren H.R., ten Kate F.J., van Berge-Henegouwen G.P., and Schalm S.W. Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. Dutch Multi-Centre PBC Study Group. J Hepatol 31 (1999) 256-262
7. Broome U., Olsson R., Loof L., Bodemar G., Hultcrantz R., Danielsson A., et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38 (1996) 610-615
8. Pares A., Caballeria L., and Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology 130 (2006) 715-720
9. Bianchi G., Marchesini G., Nicolino F., Graziani R., Sgarbi D., Loguercio C., et al. Psychological status and depression in patients with liver cirrhosis. Dig Liver Dis 37 (2005) 593-600
10. Cauch-Dudek K., Abbey S., Stewart D.E., and Heathcote E.J. Fatigue in primary biliary cirrhosis. Gut 43 (1998) 705-710
11. Huet P.M., Deslauriers J., Tran A., Faucher C., and Charbonneau J. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 95 (2000) 760-767
12. Björnsson E.M.S., Olsson R., and Chapman R.W. Fatigue in patients with primary sclerosing cholangitis. Scand J Gastroenterol 39 (2004) 760-767
13. Hamilton M. A rating scale for depression. J Neurol, Neurosurg Psychiatry 23 (1960) 56-61
14. Myers J.K., and Weissman M.M. Use of a self-report symptom scale to detect depression in a community sample. Am J Psychiatry 137 (1980) 1081-1084
15. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
16. Spitzer R., and Endicot J. Schedule for Affective Disorders and Schizophrenia (SADS). 3rd ed. (1978), Biometric Research, New York State Psychiatric Institute, New York
17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
18. Bjornsson E., Simren M., Olsson R., and Chapman R.W. Fatigue is not a specific symptom in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 17 (2005) 351-357
19. Stanca C.M., Bach N., Krause C., Tandon N., Freni M.A., Gutierrez J.A., et al. Evaluation of fatigue in U.S. patients with primary biliary cirrhosis. Am J Gastroenterol 100 (2005) 1104-1109
20. ter Borg P.C., van Os E., van den Broek W.W., Hansen B.E., and van Buuren H.R. Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634]. BMC Gastroenterol 4 (2004) 13
21. Elenkov I.J., Iezzoni D.G., Daly A., Harris A.G., and Chrousos G.P. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12 (2005) 255-269
22. Denicoff K.D., Rubinow D.R., Papa M.Z., Simpson C., Seipp C.A., Lotze M.T., et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 107 (1987) 293-300
23. Valentine A.D., Meyers C.A., Kling M.A., Richelson E., and Hauser P. Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 25 (1998) 39-47
24. Bluthe R.M., Pawlowski M., Suarez S., Parnet P., Pittman Q., Kelley K.W., et al. Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology 19 (1994) 197-207
25. Swiergiel A.H., Smagin G.N., Johnson L.J., and Dunn A.J. The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Brain Res 776 (1997) 96-104